Singapore start-up plans clinical trial of a single daily pill for Parkinson’s disease

Materials scientists from Nanyang Technological University, Singapore (NTU Singapore) have developed a new pill which uses the stomach as a drug reservoir and delivers medicines slowly over time to patients with Parkinson’s disease (PD). Parkinson’s disease is a neuro-degenerative disorder which can be treated with Levodopa (L-dopa) taken orally. L-dopa is turned into dopamine by […]

Continue Reading

Devi mangiare! Why culture may be contributing to disordered eating among women

“You have to eat!” It’s a sentiment that illustrates how central food is to Italian culture, but the woman who uttered these words also happens to be struggling with bulimia nervosa. Carmela’ is one of many Italian-Australian women who has a conflicted relationship with food which is inextricably linked to culture, according to University of […]

Continue Reading

Accurate labels like ‘aerosol’ or ‘chemicals’ increase perceived risks of e-cigarette use

A new study led by Dr. Matthew Rossheim at the George Mason University College of Health and Human Services provides important findings on how labeling of secondhand emissions from e-cigarettes can help more effectively communicate the harm from e-cigarettes and build support for tobacco-free campus policies. In the study “Aerosol, vapor, or chemicals? College student […]

Continue Reading

PPI use is negative prognostic marker in urothelial cancer

For patients with advanced urothelial cancer treated with atezolizumab, proton pump inhibitor (PPI) use is a negative prognostic marker, according to a study published online Sept. 15 in Clinical Cancer Research. Ashley M. Hopkins, Ph.D., from Flinders University in Adelaide, Australia, and colleagues pooled data from two advanced urothelial cancer trials (IMvigor210 and IMvigor211) to […]

Continue Reading